Cargando…
Is (18)F-FDG PET/CT Beneficial for Newly Diagnosed Breast Cancer Patients With Low Proportion of ER Expression?
OBJECTIVE: It is unclear whether the receptor status of breast malignancy or the proportion of receptors expression is useful in the interpretation of (18)F-FDG PET/CT. This study’s purpose was to analyze whether (18)F-FDG PET/CT was valuable for helping newly diagnosed breast cancer patients find s...
Autores principales: | Liu, Jiachen, Sun, Runlu, Yin, Yuping, Li, Jingyan, Liu, Xuming, Liu, Sheng, Zhang, Zhanlei, Hu, Jieting, Wan, Xiaoting, Zhang, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8599817/ https://www.ncbi.nlm.nih.gov/pubmed/34804947 http://dx.doi.org/10.3389/fonc.2021.755899 |
Ejemplares similares
-
Exploring the efficacy of (18)F-FDG PET/CT in hepatocellular carcinoma diagnosis: role of Ki-67 index and tumor differentiation
por: Yin, Yuping, et al.
Publicado: (2023) -
MiR-1246 regulates the PI3K/AKT signaling pathway by targeting PIK3AP1 and inhibits thyroid cancer cell proliferation and tumor growth
por: Li, Jingyan, et al.
Publicado: (2021) -
Comparison of [(18)F]fluciclovine and [(18)F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
por: Stokke, Caroline, et al.
Publicado: (2022) -
Prognostic value of semi-quantitative parameters of (18)F-FDG PET/CT in newly diagnosed multiple myeloma patients
por: Wan, Baoyu, et al.
Publicado: (2022) -
Detection of bone marrow involvement with FDG PET/CT in patients with newly diagnosed lymphoma
por: Özpolat, H. Tahsin, et al.
Publicado: (2018)